|
Jul 19
|
Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know
|
|
Jul 19
|
Gilead Sciences: Putting a Spotlight on the Mental Health Needs of LGBTQ+ Youth
|
|
Jul 19
|
Gilead Showcases Latest HIV Pipeline Progress and the Impact of Global Collaboration on Health Equity Efforts at IAS 2023
|
|
Jul 19
|
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
|
|
Jul 17
|
Gilead's (GILD) Veklury Gets FDA Nod for Label Expansion
|
|
Jul 17
|
Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash
|
|
May 26
|
Gilead's (GILD) Veklury Gets Positive CHMP View for Extended Use
|
|
May 26
|
CHMP Adopts Positive Opinion to Extend the Use of Veklury® (Remdesivir) to Treat COVID-19 in People With Severe Renal Impairment, Including Those on Dialysis
|
|
May 25
|
Gilead Sciences to Present at Upcoming Investor Conference
|
|
May 25
|
Gilead Sciences Stock Reaches 80-Plus Relative Strength Rating Benchmark
|
|
May 25
|
How Gilead’s Supportive Culture Helps Working Parents: LJ’s Story
|
|
May 25
|
Here's Why Gilead Sciences (NASDAQ:GILD) Can Manage Its Debt Responsibly
|
|
May 25
|
14 Best Biotech Stocks To Buy According To Hedge Funds
|
|
May 24
|
14 Best Healthcare Dividend Stocks to Buy
|
|
May 22
|
How To Trade Stocks: Do You Know The Seven Most Important Words On Wall Street?
|
|
May 21
|
Gilead Sciences, Inc. (NASDAQ:GILD) is favoured by institutional owners who hold 85% of the company
|